View on Pubmed.gov 2982918 | View on doi.org 10.1172/JCI1117...
Human B lymphoma cell line producing B cell growth factor.
Abstract
Namalva, a human B cell lymphoma line, produced a factor with a molecular weight of approximately 60,000 which enhanced the proliferation of normal activated human B lymphocytes. The factor also enhanced the proliferation of certain B cell lines. It can be distinguished physiologically and biochemically from other lymphokines known to enhance B cell proliferation, namely, interleukin (IL) 1, IL 2, and interferon. The production of B cell growth factor by B cell tumor lines may contribute to their ability to grow autonomously and may reflect an important component of the neoplastic potential of the cell. B cell growth factor produced by tumors may also affect normal cells in vivo.
References
Nature. 1970 Aug 15;227(5259):680-5
Nature. 1984 Jul 12-18;310(5973):145-7
J Virol. 1976 Mar;17(3):935-49
J Immunol. 1977 Jan;118(1):77-82
Cited by 116 citations (total)
Journal Article Research Support, Non-U.S. Gov't
CD40 expression in Hodgkin's disease.
Electronic publication date January 1, 1994
J T O'Grady [...] A S Krajewski et al.
CD40 is a transmembrane protein that belongs to a superfamily of proteins related to nerve growth factor receptor. CD40 is...
Journal Article
Association between B Cell Growth Factors and Primary Sjögren's Syndrome-Related Autoantibodies in Patients with Non-Hodgkin's Lymphoma.
Electronic publication date April 9, 2019
Zhenhua Xian [...] Chun Gao et al.
Despite the overall success of using R-CHOP for the care for non-Hodgkin's lymphoma patients, it is clear that the disease...
Conflict of interest statement
MeSH
Specialties
Substances
- •
- •